SCHEMBL18399110

SCHEMBL18399110

CN1CCOC(c2ccc3cn[nH]c3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 6/20 0.50
SLC6A4 P31645 6/20 0.50
SLC6A3 Q01959 6/20 0.50
CYP2D6 P10635 3/20 0.41
KCNH2 Q12809 1/20 0.41
CHEK1 O14757 1/20 0.40
NOS1 P29475 2/20 0.38
DYRK1A Q13627 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
METAP2 P50579 1/20 0.38
BRD4 O60885 2/20 0.37
KDM1A O60341 1/20 0.37
PLK4 O00444 3/20 0.37
CYP2C19 P33261 1/20 0.37
FLT3 P36888 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21796820 0.73 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CHEK1NOS1
SCHEMBL21796799 0.73 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CHEK1NOS1
SCHEMBL15345152 0.73 DRD4 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL15345157 0.73 DRD4 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL15345158 0.73 DRD4 (0.43) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL18399112 0.72 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3NOS1DYRK1A
SCHEMBL10747371 0.70 PDE10A (0.46) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL24322379 0.69 DRD3 (0.55) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL31116847 0.69 DRD3 (0.55) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL13634382 0.69 DRD3 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3325449-A1 COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-05-30 EP disclosed
WO-2017012576-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-01-26 WO disclosed